What are the active ingredients of Zertalin?

Answer 1

ZERTALIN contains azitromicina, that is a azálido antibiotic, a new antibiotic group originated from the eritro-micina. The azitromicina is indicated in the infections caused by susceptible organisms; in infections of the respiratory tract inferior, that include bronchitis and pneumonia, as well as soft infections of skin and weaves, in average otitis and infections of the respiratory tract superior, that include sinusitis and faringoamigdalitis. (Penicillin is generally the drug of election in the treatment of the faringitis by Streptococcus pyogenes, as well as in the prophylaxis of the rheumatic fever. The azitromicina is generally effective in the eradication of the estreptococos of the oro-pharynx; nevertheless, at the moment data available do not exist that establish the effectiveness of the azitromicina in the subsequent prevention of the rheumatic fever). In infections transmitted sexually, the azitromicina is indicated so much in the man as in the woman in the treatment of noncomplicated genital infections due to Chlamydia trachomatis. Also ducreyi is indicated for the treatment of chancroide due to Haemophilus. Also gonorrhoeae is indicated in the treatment of noncomplicated genital infections due to Neisseria that is not multiresistant. The concomitant infection by Treponema will have to be excluded pallidum. The azitromicina has demonstrated test-tube activity against an ample phantom of bacteria that they include: Grampositivas aerobic bacteria: Staphylococcus aureus, Streptococcus pyogenes (estreptococo beta haemolytic group A), haemolytic Streptococcus pneumoniae, estreptococos alpha (group viridans), other estreptococos and Corynebacterium diphtheriae. The azitromicina has demonstrated resistance crossed to the eritromicina in resistant grampositivas stocks that one, that they include: Streptococcus faecalis (enterococo) and the majority of the meticilino-resistant stocks of estafilococos. Gramnegativas aerobic bacteria: Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, species of Acinetobacter, species of Yersinia, Legionella pneumophilia, Bordetella pertussis, Bordetella parapertussis, species of Shigella, shigelloides species of Pasteurella, Vibrio cholerae and parahaemolyticus, Plesiomonas. The activity against Escherichia coli, Salmonella enteritidis, Salmonella typhi, species of Enterobacter, Aeromonas hydrophila and species of Klebsiella is variable and will have to test of susceptibility. ZERTALIN contains azitromicina, that is a azálido antibiotic, a new antibiotic group originated from the eritro-micina. The azitromicina is indicated in the infections caused by susceptible organisms; in infections of the respiratory tract inferior, that include bronchitis and pneumonia, as well as soft infections of skin and weaves, in average otitis and infections of the respiratory tract superior, that include sinusitis and faringoamigdalitis. (Penicillin is generally the drug of election in the treatment of the faringitis by Streptococcus pyogenes, as well as in the prophylaxis of the rheumatic fever. The azitromicina is generally effective in the eradication of the estreptococos of the oro-pharynx; nevertheless, at the moment data available do not exist that establish the effectiveness of the azitromicina in the subsequent prevention of the rheumatic fever). In infections transmitted sexually, the azitromicina is indicated so much in the man as in the woman in the treatment of noncomplicated genital infections due to Chlamydia trachomatis. Also ducreyi is indicated for the treatment of chancroide due to Haemophilus. Also gonorrhoeae is indicated in the treatment of noncomplicated genital infections due to Neisseria that is not multiresistant. The concomitant infection by Treponema will have to be excluded pallidum. The azitromicina has demonstrated test-tube activity against an ample phantom of bacteria that they include: Grampositivas aerobic bacteria: Staphylococcus aureus, Streptococcus pyogenes (estreptococo beta haemolytic group A), haemolytic Streptococcus pneumoniae, estreptococos alpha (group viridans), other estreptococos and Corynebacterium diphtheriae. The azitromicina has demonstrated resistance crossed to the eritromicina in resistant grampositivas stocks that one, that they include: Streptococcus faecalis (enterococo) and the majority of the meticilino-resistant stocks of estafilococos. Gramnegativas aerobic bacteria: Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, species of Acinetobacter, species of Yersinia, Legionella pneumophilia, Bordetella pertussis, Bordetella parapertussis, species of Shigella, shigelloides species of Pasteurella, Vibrio cholerae and parahaemolyticus, Plesiomonas. The activity against Escherichia coli, Salmonella enteritidis, Salmonella typhi, species of Enterobacter, Aeromonas hydrophila and species of Klebsiella is variable and will have to test of susceptibility.